Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study

被引：0
|
作者：
B. M. M. Kremers
J. H. C. Daemen
H. ten Cate
H. M. H. Spronk
B. M. E. Mees
A. J. ten Cate-Hoek
机构：
[1] Maastricht University,Department of Biochemistry, Laboratory for Clinical Thrombosis and Hemostasis
[2] Maastricht University Medical Center,Department of Vascular Surgery
[3] Maastricht University Medical Center,Thrombosis Expertise Center
[4] Maastricht University Medical Center,Department of Internal Medicine
[5] Gutenberg University Medical Center,Center for Thrombosis and Hemostasis
来源：
Thrombosis Journal | / 21卷
关键词：
Atherosclerosis; Atherothrombosis; Peripheral artery disease; Cardiovascular risk; Antiplatelet therapy; High on-treatment platelet reactivity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Corrected QT Interval and Outcomes of Dialysis Patients with Symptomatic Peripheral Artery Disease: A Prospective Cohort Study
    Lin, Shuang-Chin
    Chou, Hsin-Hua
    Lin, Ting-Yun
    Huang, Hsuan-Li
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [22] Antithrombotic therapy in peripheral artery disease - antiplatelet therapy, anticoagulants, both or none
    Tangelder, Marco J. D.
    van Hattum, Eline S.
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (02) : 196 - 199
  • [23] Antiplatelet therapy in patients with peripheral arterial disease (PAD)
    Diehm, C
    Lawall, H
    Huber, R
    MEDIZINISCHE KLINIK, 2004, 99 : 14 - 20
  • [24] Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease
    Tran, H
    Anand, SS
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (15): : 1867 - 1874
  • [25] Peripheral artery disease and antiplatelet treatment
    Tsigkou, Vasiliki
    Siasos, Gerasimos
    Rovos, Kleanthis
    Tripyla, Niki
    Tousoulis, Dimitris
    CURRENT OPINION IN PHARMACOLOGY, 2018, 39 : 43 - 52
  • [26] Antiplatelet therapy and risk of adverse cardiovascular events in peripheral artery disease
    Kamil, S.
    Sehested, T. S. G.
    Blanche, P.
    Houlind, K.
    Lassen, J. F.
    Gislasonl, G.
    Dorninguez, H.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2321 - 2321
  • [27] Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients
    Pierre Sabouret
    Michael P. Savage
    David Fischman
    Francesco Costa
    American Journal of Cardiovascular Drugs, 2021, 21 : 21 - 34
  • [28] Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients
    Sabouret, Pierre
    Savage, Michael P.
    Fischman, David
    Costa, Francesco
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (01) : 21 - 34
  • [29] Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant A Nationwide Cohort Study
    Lamberts, Morten
    Gislason, Gunnar H.
    Lip, Gregory Y. H.
    Lassen, Jens Flensted
    Olesen, Jonas Bjerring
    Mikkelsen, Anders P.
    Sorensen, Rikke
    Kober, Lars
    Torp-Pedersen, Christian
    Hansen, Morten Lock
    CIRCULATION, 2014, 129 (15) : 1577 - 1585
  • [30] Traditional Chinese Medicine for Patients of Coronary Artery Disease: Savior or Troublemaker? A Cohort Study About the Adherence to Antiplatelet Therapy
    Chao Feng
    Fuxu Chen
    Liang Li
    Qiming Li
    Shudong Xia
    Journal of General Internal Medicine, 2022, 37 (4) : 981 - 983
12345